Dr. Jenkins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MGH Cancer Center
55 Street, Jackson 904B
Boston, MA 02114Phone+1 617-726-9372Fax+1 844-542-5959
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2014 - 2018
Massachusetts General HospitalResidency, Internal Medicine, 2013 - 2014- Massachusetts General HospitalInternship, Internal Medicine, 2012 - 2013
Medical University of South CarolinaClass of 2012
Certifications & Licensure
MA State Medical License 2015 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids.Yi Sun, Luke Maggs, Apekshya Panda, Samuel J Wright, Angelina M Cicerchia
Cancer Immunology Research. 2025-02-03 - Real-world data confirms limited efficacy of dual programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 immune checkpoint blockade in acral l...David X Zheng, Russell W Jenkins
The British Journal of Dermatology. 2025-01-24 - Overcoming Resistance Mechanisms to Melanoma Immunotherapy.David X Zheng, David J Bozym, Giuseppe Tarantino, Ryan J Sullivan, David Liu
American Journal of Clinical Dermatology. 2025-01-01
Journal Articles
- Tumor Innate Immunity Primed by Specific Interferon-Stimulated Endogenous RetrovirusesScott Rodig, Ewa Sicinska, Thanh Uyen Barbie, David Allen Barbie, Russell William Jenkins, Ravindra Uppaluri, Rohit Thummalapalli, Jacob Sands, Nature
Press Mentions
Study Identifies TBK1 as Key to Overcoming CAR T ResistanceJanuary 9th, 2025
Melanoma Research Alliance Announces $8.2 Million for 33 Grant Awards to Advance Melanoma ResearchApril 30th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
